Answers are grounded in this paper and cite their sources.
Eight patients developed a syndrome marked by features of catatonia (including posturing, waxy flexibility, withdrawal and regression) and parkinsonism (including bradykinesia and rigidity) while receiving high-potency neuroleptic drugs. The syndrome had a gradual onset, responded slowly to withdrawal of the neuroleptic or use of an anticholinergic agent, but seemed to respond more rapidly to amantadine. The syndrome may easily be confused with a worsening of schizophrenic symptoms.
No takes yet. Share an insight, caveat, or question.
Alan J. Gelenberg (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: